Karyopharm Therapeutics Inc. KPTI reported mixed financial results for the first quarter on Monday. The company posted ...

Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced its abstract has been selected for a poster presentation at ...

Karyopharm Therapeutics (KPTI) delivered earnings and revenue surprises of 34.20% and 16.18%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock ...

In this article, we are going to take a look at where Karyopharm Therapeutics Inc. (NASDAQ:KPTI) stands against the other one-dollar stocks. The upward trend in the stock market has resumed ...

NEWTON, Mass. (AP) — NEWTON, Mass. (AP) — Karyopharm Therapeutics Inc. (KPTI) on Monday reported a loss of $23.5 million in its first quarter. On a per-share basis, the Newton, Massachusetts-based ...

Karyopharm Therapeutics Inc.’s KPTI share price has dipped by 5.15%, which has investors questioning if this is right time to buy.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

NEWTON, Mass. (AP) — NEWTON, Mass. (AP) — Karyopharm Therapeutics Inc. (KPTI) on Monday reported a loss of $23.5 million in its first quarter. On a per-share basis, the Newton, Massachusetts ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...